Association of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. Petersburg
Authors:
- 1 September 2011
- journal article
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics: Applied Research
- Vol. 1 (5) , 411-415
Abstract
Apoprotein A-1 is the major protein of antiatherogenic high density lipoproteins and one of the key proteins regulating reverse cholesterol transport. The goal of this work was to study the association of the APOA1 gene polymorphism with development of atherosclerosis in the population of St. Petersburg. Allelic frequencies of polymorphic variants (−75)G/A and 83C/T of the APOA1 gene were determined in a group of patients with angiographically proven atherosclerosis and in the control group. Allele 83T of the APOA1 gene was associated with a lower risk of developing atherosclerosis in residents of St. Petersburg.Keywords
This publication has 19 references indexed in Scilit:
- Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesityClinical and Experimental Medicine, 2009
- Evidence for Consistent Intragenic and Intergenic Interactions between SNP Effects in the APOA1/C3/A4/A5 Gene ClusterHuman Heredity, 2006
- APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian childrenBrazilian Journal of Medical and Biological Research, 2005
- APOA1‐75 G to A Substitution Associated with Severe Forms of CAD, Lower Levels of HDL and apoA‐I among Northern IndiansDisease Markers, 2005
- Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent dataDiabetes & Metabolism, 2003
- MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.Diabetes Care, 2000
- Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: A meta-analysisAmerican Journal of Medical Genetics, 1999
- Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of Apo A-I and HDL-cholesterolAtherosclerosis, 1996
- Association of a polymorphism in the apo AI gene promoter with hyperalphalipoproteinemiaEuropean Journal of Epidemiology, 1992
- Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene.Proceedings of the National Academy of Sciences, 1991